Precision BioSciences (DTIL) Tops Q1 EPS by 1c

Precision BioSciences (NASDAQ: DTIL) reported Q1 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $8.78 million versus the consensus estimate of $6.88 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• INVO Fertility (IVF) Tops Q2 EPS by 105c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c